Antiviral composition as well as preparation method and application thereof

An anti-virus and composition technology, which is applied in the field of anti-virus composition and its preparation, can solve the problems of stuffy masks, patient body damage, side effects, etc.

Pending Publication Date: 2021-09-07
ZHUKANG BIOTECHNOLOGY CO LTD
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, no specific drug that can kill the new coronavirus has been found, and the drugs used in the existing treatment methods all have certain side effects, which can cause short-term or long-term body damage to patients
[0003] Although wearing a mask is a convenient protective measure against the transmission of droplets and aerosols, it can only block virus-carrying droplets and aerosols from entering the respiratory tract to a certain extent. The weaker the protective ability of the mask, the worse the effect of blocking viruses
On the other hand, masks with strong protective ability are usually stuffy, and the water is not easy to leak out. Wearing them for a long time will make the nasal mucosa weak and lose its original physiological functions, and the resistance will be reduced. more susceptible to infection
Moreover, all kinds of masks are only used as barriers to isolate viruses, and they do not have the effect of preventing diseases and inhibiting or killing anti-viruses.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] The embodiment of the present invention provides an antiviral composition, including the following raw materials in parts by weight: 0.0001 part of Ravensah leaf essential oil, 0.0001 part of oregano essential oil, 0.0001 part of tea tree essential oil, 73 parts of chlorophyll derivatives, monoglycerol laurate 1 part of ester; wherein, the preparation method of chlorophyll derivatives is as follows: mix 20 parts of fig leaf powder, 20 parts of pagoda leaf powder, 80 parts of corn flour, 20 parts of soybean powder and 8 parts of sodium carbonate, add water to paste, let stand After 30-60 minutes, add 8,000-10,000 parts of water, mix well, adjust the pH value to 8.0 with sodium hydroxide, and sterilize to obtain a culture medium; inoculate the culture medium with cereus spores under the condition of 28-30°C The bacillus CGMCC0601 is fermented under the condition of 28-30° C.; after the fermentation is finished, the obtained fermented liquid is filtered, and the obtained fi...

Embodiment 2

[0035] The embodiment of the present invention provides an antiviral composition, comprising the following raw materials in parts by weight: 1.2 parts of eucalyptus essential oil, 0.02 part of oregano essential oil, 0.03 part of tea tree essential oil, 95 parts of chlorophyll derivatives and monolauric acid 30 parts of glycerides; wherein, the preparation method of chlorophyll derivatives is as follows: 30 parts of fig leaf powder, 35 parts of locust leaf powder, 100 parts of corn flour, 30 parts of soybean powder and 10 parts of sodium carbonate are mixed and then added to paste, static Leave it for 60 minutes, then add 10,000 parts of water, adjust the pH value to 8.5 with sodium hydroxide after mixing evenly, and sterilize to obtain a medium; under the condition of 28-30°C, inoculate the medium with Bacillus cereus CGMCC0601, The fermentation is carried out under the condition of 28-30 DEG C; after the fermentation is finished, the obtained fermentation liquid is filtered, a...

Embodiment 3

[0038] An embodiment of the present invention provides an antiviral composition, comprising the following raw materials in parts by weight: 0.02 parts of eucalyptus essential oil, 1.2 parts of oregano essential oil, 0.03 parts of tea tree essential oil, 95 parts of chlorophyll derivatives and monolauric acid 30 parts of glyceride; Wherein, the preparation method of chlorophyll derivative and the preparation method of this antiviral composition are the same as embodiment 2.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of virus control, in particular to an antiviral composition as well as a preparation method and application thereof. The antiviral composition is prepared from the following raw materials: ravensara leaf essential oil or eucalyptus essential oil, oregano essential oil, tea tree essential oil, a chlorophyll derivative and glycerol monolaurate. The antiviral composition achieves the effects of capturing, inhibiting and killing viruses in different aspects and levels through combination of pharmaceutical effects and physical effects, and has broad-spectrum, efficient and multi-aspect antiviral effects. Moreover, featured by small dosage, strong effect, lasting action time and safety in use, the antiviral composition can greatly reduce the probability that an organism is infected with respiratory viruses.

Description

technical field [0001] The invention relates to the technical field of virus prevention and treatment, in particular to an antiviral composition and its preparation method and application. Background technique [0002] The respiratory tract is one of the main routes of transmission of viruses such as rhinovirus, coronavirus, enterovirus, adenovirus, and respiratory syncytial virus. The above-mentioned viruses can cause upper respiratory tract infection and spread downward to cause different degrees of lung inflammation. According to statistics, more than 30% of upper respiratory tract infections in the world are caused by coronaviruses. The new coronavirus (2019-nCoV) newly discovered in 2019 can be transmitted through respiratory droplets, aerosols and close contact, and the incubation period can be as long as 14 days, and the asymptomatic incubation period is also contagious, so the transmission is strong and difficult Take precautions. Respiratory symptoms, fever, cough...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/21A61K36/61A61P31/12A41D13/11A61K31/555
CPCA61K31/555A61K38/21A61K36/54A61K36/61A61K36/53A61K9/0048A61P31/12A41D13/1192A61K2300/00
Inventor 齐锦生敦楚洋刘立娟
Owner ZHUKANG BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap